Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health (PRTC) Common Equity (2019 - 2025)

PureTech Health (PRTC) has disclosed Common Equity for 6 consecutive years, with $312.1 million as the latest value for Q4 2025.

  • For Q4 2025, Common Equity changed N/A year-over-year to $312.1 million; the TTM value through Dec 2025 reached $312.1 million, changed N/A, while the annual FY2025 figure was $312.1 million, N/A changed from the prior year.
  • Common Equity hit $312.1 million in Q4 2025 for PureTech Health, down from $464.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $593.5 million in Q4 2021 and bottomed at $312.1 million in Q4 2025.
  • Average Common Equity over 4 years is $478.0 million, with a median of $503.1 million recorded in 2022.
  • Year-over-year, Common Equity decreased 8.64% in 2022 and then dropped 14.41% in 2023.
  • PureTech Health's Common Equity stood at $593.5 million in 2021, then decreased by 8.64% to $542.2 million in 2022, then decreased by 14.41% to $464.1 million in 2023, then plummeted by 32.75% to $312.1 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $312.1 million, $464.1 million, and $542.2 million for Q4 2025, Q4 2023, and Q4 2022 respectively.